CHERRY SE (C3RY.DE) Fundamental Analysis & Valuation

FRA:C3RY • DE000A3CRRN9

Current stock price

0.485 EUR
-0.01 (-2.81%)
Last:

This C3RY.DE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. C3RY.DE Profitability Analysis

1.1 Basic Checks

  • C3RY had negative earnings in the past year.
  • C3RY had a negative operating cash flow in the past year.
  • In the past 5 years C3RY reported 4 times negative net income.
  • C3RY had a positive operating cash flow in 4 of the past 5 years.
C3RY.DE Yearly Net Income VS EBIT VS OCF VS FCFC3RY.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 0 -50M -100M

1.2 Ratios

  • C3RY has a Return On Assets of -39.96%. This is amonst the worse of the industry: C3RY underperforms 90.63% of its industry peers.
  • C3RY's Return On Equity of -92.41% is on the low side compared to the rest of the industry. C3RY is outperformed by 75.00% of its industry peers.
Industry RankSector Rank
ROA -39.96%
ROE -92.41%
ROIC N/A
ROA(3y)-29.88%
ROA(5y)-18%
ROE(3y)-58.91%
ROE(5y)-35.77%
ROIC(3y)N/A
ROIC(5y)N/A
C3RY.DE Yearly ROA, ROE, ROICC3RY.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 0 -20 -40 -60 -80 -100

1.3 Margins

  • C3RY has a Gross Margin of 8.78%. This is amonst the worse of the industry: C3RY underperforms 84.38% of its industry peers.
  • In the last couple of years the Gross Margin of C3RY has declined.
  • The Profit Margin and Operating Margin are not available for C3RY so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 8.78%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-19.07%
GM growth 5YN/A
C3RY.DE Yearly Profit, Operating, Gross MarginsC3RY.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 0 -50 -100

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

2

2. C3RY.DE Health Analysis

2.1 Basic Checks

  • C3RY does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • C3RY has about the same amout of shares outstanding than it did 1 year ago.
  • Compared to 1 year ago, C3RY has an improved debt to assets ratio.
C3RY.DE Yearly Shares OutstandingC3RY.DE Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 5M 10M 15M 20M
C3RY.DE Yearly Total Debt VS Total AssetsC3RY.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 100M 200M 300M 400M

2.2 Solvency

  • C3RY has an Altman-Z score of -2.48. This is a bad value and indicates that C3RY is not financially healthy and even has some risk of bankruptcy.
  • With a Altman-Z score value of -2.48, C3RY is not doing good in the industry: 87.50% of the companies in the same industry are doing better.
  • C3RY has a Debt/Equity ratio of 0.59. This is a neutral value indicating C3RY is somewhat dependend on debt financing.
  • C3RY has a Debt to Equity ratio (0.59) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.59
Debt/FCF N/A
Altman-Z -2.48
ROIC/WACCN/A
WACC4.7%
C3RY.DE Yearly LT Debt VS Equity VS FCFC3RY.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 0 100M 200M

2.3 Liquidity

  • C3RY has a Current Ratio of 1.99. This is a normal value and indicates that C3RY is financially healthy and should not expect problems in meeting its short term obligations.
  • C3RY has a Current ratio of 1.99. This is in the better half of the industry: C3RY outperforms 71.88% of its industry peers.
  • C3RY has a Quick Ratio of 1.99. This is a bad value and indicates that C3RY is not financially healthy enough and could expect problems in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 0.85, C3RY is doing worse than 65.63% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.99
Quick Ratio 0.85
C3RY.DE Yearly Current Assets VS Current LiabilitesC3RY.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 50M 100M 150M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. C3RY.DE Growth Analysis

3.1 Past

  • C3RY shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 58.81%, which is quite impressive.
  • The Revenue for C3RY has decreased by -20.62% in the past year. This is quite bad
  • The Revenue for C3RY have been decreasing by -13.14% on average. This is quite bad
EPS 1Y (TTM)58.81%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%16.13%
Revenue 1Y (TTM)-20.62%
Revenue growth 3Y-13.14%
Revenue growth 5YN/A
Sales Q2Q%8.94%

3.2 Future

  • C3RY is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 25.61% yearly.
  • The Revenue is expected to grow by 2.13% on average over the next years.
EPS Next Y-31.51%
EPS Next 2Y27.32%
EPS Next 3Y25.61%
EPS Next 5YN/A
Revenue Next Year-13.59%
Revenue Next 2Y-3.24%
Revenue Next 3Y0.19%
Revenue Next 5Y2.13%

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
C3RY.DE Yearly Revenue VS EstimatesC3RY.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 50M 100M 150M
C3RY.DE Yearly EPS VS EstimatesC3RY.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 0 0.5 -0.5 -1

More info and screens

Find the best growth stocksShow best growing peers

1

4. C3RY.DE Valuation Analysis

4.1 Price/Earnings Ratio

  • C3RY reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Also next year C3RY is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
C3RY.DE Price Earnings VS Forward Price EarningsC3RY.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60 80 100

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
C3RY.DE Per share dataC3RY.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2

4.3 Compensation for Growth

  • C3RY's earnings are expected to grow with 25.61% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y27.32%
EPS Next 3Y25.61%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. C3RY.DE Dividend Analysis

5.1 Amount

  • No dividends for C3RY!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

C3RY.DE Fundamentals: All Metrics, Ratios and Statistics

CHERRY SE

FRA:C3RY (3/20/2026, 7:00:00 PM)

0.485

-0.01 (-2.81%)

Chartmill FA Rating
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryTechnology Hardware, Storage & Peripherals
Earnings (Last)08-14
Earnings (Next)N/A
Inst Owners30.97%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap11.79M
Revenue(TTM)96.91M
Net Income(TTM)-52.02M
Analysts44
Price Target0.66 (36.08%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-3.6%
EPS NY rev (3m)-3.6%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-1.86%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.12
P/FCF N/A
P/OCF N/A
P/B 0.21
P/tB 3.88
EV/EBITDA N/A
EPS(TTM)-2.21
EYN/A
EPS(NY)-0.28
Fwd EYN/A
FCF(TTM)-0.32
FCFYN/A
OCF(TTM)-0.06
OCFYN/A
SpS3.99
BVpS2.32
TBVpS0.12
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -39.96%
ROE -92.41%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 8.78%
FCFM N/A
ROA(3y)-29.88%
ROA(5y)-18%
ROE(3y)-58.91%
ROE(5y)-35.77%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-19.07%
GM growth 5YN/A
F-Score4
Asset Turnover0.74
Health
Industry RankSector Rank
Debt/Equity 0.59
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 17.21%
Cap/Sales 6.45%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.99
Quick Ratio 0.85
Altman-Z -2.48
F-Score4
WACC4.7%
ROIC/WACCN/A
Cap/Depr(3y)17.41%
Cap/Depr(5y)38.92%
Cap/Sales(3y)6.91%
Cap/Sales(5y)6.78%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)58.81%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%16.13%
EPS Next Y-31.51%
EPS Next 2Y27.32%
EPS Next 3Y25.61%
EPS Next 5YN/A
Revenue 1Y (TTM)-20.62%
Revenue growth 3Y-13.14%
Revenue growth 5YN/A
Sales Q2Q%8.94%
Revenue Next Year-13.59%
Revenue Next 2Y-3.24%
Revenue Next 3Y0.19%
Revenue Next 5Y2.13%
EBIT growth 1Y34.02%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-3.56%
EBIT Next 3Y44.3%
EBIT Next 5YN/A
FCF growth 1Y76.96%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y93.89%
OCF growth 3Y-28.61%
OCF growth 5YN/A

CHERRY SE / C3RY.DE Fundamental Analysis FAQ

What is the ChartMill fundamental rating of CHERRY SE (C3RY.DE) stock?

ChartMill assigns a fundamental rating of 2 / 10 to C3RY.DE.


What is the valuation status of CHERRY SE (C3RY.DE) stock?

ChartMill assigns a valuation rating of 1 / 10 to CHERRY SE (C3RY.DE). This can be considered as Overvalued.


Can you provide the profitability details for CHERRY SE?

CHERRY SE (C3RY.DE) has a profitability rating of 1 / 10.


What is the expected EPS growth for CHERRY SE (C3RY.DE) stock?

The Earnings per Share (EPS) of CHERRY SE (C3RY.DE) is expected to decline by -31.51% in the next year.